These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16810405)

  • 41. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A musician's dystonia.
    Vecchio M; Malaguarnera G; Giordano M; Malaguarnera M; Li Volti G; Galvano F; Drago F; Basile F; Malaguarnera M
    Lancet; 2012 Jun; 379(9831):2116. PubMed ID: 22656885
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Jan; 77(1):41-4. PubMed ID: 10333697
    [No Abstract]   [Full Text] [Related]  

  • 47. Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
    Rauchverger B; Isakov V; Jabarin M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):484-5. PubMed ID: 18070868
    [No Abstract]   [Full Text] [Related]  

  • 48. Complete secondary botulinum toxin therapy failure in blepharospasm.
    Dressler D
    J Neurol; 2000 Oct; 247(10):809-10. PubMed ID: 11127541
    [No Abstract]   [Full Text] [Related]  

  • 49. [Torticollis spasmodicus as a manifestation of tardive dystonia].
    Silberbauer C; Rittmannsberger H
    Fortschr Neurol Psychiatr; 1995 Oct; 63(10):388-92. PubMed ID: 8529987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin for headache.
    Rosch PJ
    Mayo Clin Proc; 2006 Jan; 81(1):133. PubMed ID: 16438492
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 53. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 55. Local side effects of botulinum toxin injections.
    Patrinely JR; Whiting AS; Anderson RL
    Adv Neurol; 1988; 49():493-500. PubMed ID: 3278553
    [No Abstract]   [Full Text] [Related]  

  • 56. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of treatment with botulinum toxin on neurogenic blepharospasm.
    Elston JS; Russell RW
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1857-9. PubMed ID: 3924284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 60. Jaw-opening dystonia: Quality of life after botulinum toxin injections.
    Charous SJ; Comella CL; Fan W
    Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.